Accurate Education - N-Acetylcysteine (NAC) for Chronic Pain: A Patient Guide

Nutraceuticals:

N-Acetylcysteine (NAC) for Chronic Pain: A Patient Guide

N-Acetylcysteine (NAC) is an antioxidant and anti-inflammatory agent showing promise for managing chronic pain, particularly neuropathic, musculoskeletal, and endometriosis-related pain.

See:

Nutraceutical Patient Guides:

Key to Links:

Grey text – handout
Red text – another page on this website
Blue text – Journal publication

Definitions and Terms Related to Pain

N-Acetylcysteine (NAC) for Chronic Pain: A Patient Guide

1. OVERVIEW

N-Acetylcysteine (NAC) is a derivative of the amino acid L-cysteine that serves as a precursor to glutathione (GSH), the body’s most important intracellular antioxidant.[1][2] NAC has been used clinically for over 60 years as a mucolytic agent and as the standard antidote for acetaminophen (paracetamol) overdose, and it is included on the World Health Organization’s list of essential medicines.[3][4]

What makes NAC valuable for chronic pain:

Potent antioxidant that increases intracellular glutathione levels[1][2][5]
Anti-inflammatory agent that reduces TNF-α, IL-6, and IL-1β by suppressing NF-κB[1]
Inhibits matrix metalloproteinases (MMP-9/2) involved in neuropathic pain[6]
Modulates glutamate neurotransmission via mGlu2 receptor activation[7][8]
Antagonizes nerve growth factor (NGF)-TrkA signaling involved in nociception[9]
Reduces microglial activation and neuroinflammation[6][10]
Excellent safety profile with decades of clinical use[1][11]
Inexpensive and widely available[12]

How NAC Compares to Conventional Medications:

A systematic review and meta-analysis of 9 studies evaluating NAC for chronic pain conditions found that while pooled analysis of RCTs did not show significant pain reduction with random-effects modeling, sensitivity analysis with fixed-effect modeling demonstrated effects for pain intensities and function.[13] The evidence base for NAC in chronic pain is still developing, with most studies being small and heterogeneous.

Unlike NSAIDs, NAC does not cause gastrointestinal ulceration, cardiovascular risks, or renal toxicity. NAC has shown particular promise in conditions characterized by oxidative stress and inflammation, including complex regional pain syndrome (CRPS), endometriosis-related pain, and inflammatory pain conditions.[14][15] NAC works best as an adjunctive therapy targeting the oxidative stress and inflammatory components of chronic pain.

—

2. DIETARY SOURCES

NAC itself is not found naturally in foods—it is a synthetic derivative of L-cysteine.[16] However, cysteine and cysteine precursors are available from dietary sources:

Onion: NAC is a plant antioxidant naturally found in onion[16]
High-protein foods: Poultry, eggs, dairy, and legumes provide L-cysteine
Whey protein: Cysteine-rich protein that can boost glutathione synthesis[17]
Cruciferous vegetables: Broccoli, Brussels sprouts, and cabbage contain sulfurompounds
Garlic and allium vegetables: Contain sulfur-containing amino acids

Important Bioavailability Note: Dietary cysteine intake alone is typically insufficient to achieve therapeutic glutathione replenishment in conditions of oxidative stress.[5][17]

Key considerations:

L-cysteine is a conditionally essential amino acid that becomes essential during stress and inflammatory states[17]
NAC has approximately 6-10% oral bioavailability, with peak plasma concentrations achieved within 1-2 hours[18]
NAC is rapidly metabolized and incorporated into proteins, with a terminal half-life of approximately 6.25 hours[18]
Protein binding reaches approximately 50% at 4 hours after dosing[18]
NAC’s primary value is as a cysteine donor for glutathione synthesis in cells depleted of GSH[5]

—

3. INDICATIONS FOR NUTRACEUTICAL SUPPLEMENTATION

Pain Conditions with Emerging Evidence:

Complex Regional Pain Syndrome (CRPS) – Moderate Quality Evidence

RCT (146 patients): NAC 600 mg three times daily showed comparable efficacy to DMSO for CRPS-I overall; NAC was more effective for “cold” CRPS-I subtype, while DMSO was more effective for “warm” CRPS-I[19]
Retrospective study (60 patients): NAC 600 mg daily for 3 months reduced CRPS-I incidence by 78% following distal radius fractures (9.7% vs 31.0%, p=0.039) and significantly reduced inflammatory markers (IL-6, TNF-α, IL-1β) and oxidative stress[14]
Cochrane overview: Low-certainty evidence that topical DMSO may not reduce pain intensity compared with oral NAC[20]

Endometriosis-Related Pelvic Pain – Moderate Quality Evidence

Prospective study (120 patients): NAC 600 mg, 3 tablets/day for 3 consecutive days weekly for 3 months significantly improved dysmenorrhea, dyspareunia, and chronic pelvic pain (p0.0001), reduced endometrioma size (p0.0001), and decreased Ca125 levels[15]
Open-label trial (398 patients): Combination of NAC, alpha-lipoic acid, and bromelain for 6 months significantly reduced endometriosis-associated pelvic pain (p0.05)[21]
Preclinical evidence: NAC suppresses oxidation-sensitive nociception in endometriosis[22]

Neuropathic Pain – Low-Moderate Quality Evidence (Primarily Preclinical)

Animal studies: Oral NAC (50-200 mg/kg) attenuated neuropathic pain by suppressing MMP-9/2, blocking IL-1β maturation, and inhibiting microglial activation[6]
Human study: NAC 1.2 g significantly reduced pain ratings to laser stimuli and laser-evoked potential amplitudes in healthy volunteers[7]
Preclinical: NAC causes analgesia via mGlu2 receptor activation in inflammatory pain models; tolerance may develop in neuropathic pain models[8]

Inflammatory Pain – Low-Moderate Quality Evidence

Animal studies: NAC showed sustained analgesic activity in chronic inflammatory pain (CFA model) without tolerance development[8]
Mechanism: NAC activates the cystine/glutamate antiporter, enhancing endogenous mGlu2 receptor activation[8]

Low Back Pain – Low Quality Evidence (Emerging)

Scoping review (16 studies): NAC shows potential for low back pain treatment based on limited clinical trials and preclinical studies; more research needed before clinical recommendation[12]
Preclinical: NAC-derived carbon dots show promise for intervertebral disc degeneration by scavenging free radicals[23]

Sickle Cell Disease Pain – Low Quality Evidence

Cochrane review: NAC 1200 mg may not be better than placebo at reducing pain days or severity in sickle cell disease (low-certainty evidence)[24]
Phase II trial (21 patients): NAC 2400 mg/day decreased dense cell formation, increased glutathione levels, and showed a trend toward decreased vaso-occlusive episodes[25]

—

4. NAC’S IMPACT ON PAIN CONDITIONS

NAC addresses the underlying pathophysiology of chronic pain conditions through multiple mechanisms:

Antioxidant Effects (Primary Mechanism):

Serves as a precursor for glutathione (GSH) synthesis, the body’s primary intracellular antioxidant[1][2][5]
Increases intracellular GSH concentrations in GSH-depleted cells[5]
Reduces lipid hydroperoxides and oxidative stress markers[26]
Decreases thiobarbituric acid reactive substances (TBARS) and increases GSH after exercise[27]
May generate hydrogen sulfide and sulfane sulfur species with cytoprotective activity[3]

Anti-Inflammatory Effects:

Reduces TNF-α, IL-6, and IL-1β by suppressing NF-κB activity[1]
Inhibits matrix metalloproteinases (MMP-9/2) that facilitate inflammatory cytokine maturation[6]
Blocks IL-1β maturation in neural tissues[6]
Reduces proinflammatory cytokines and oxidative stress markers in CRPS[14]

Neuromodulatory Effects:

Activates mGlu2 receptors via the cystine/glutamate antiporter (System xc-), causing analgesia[7][8]
Antagonizes NGF-TrkA signaling involved in nociception by disrupting disulfide bridges[9]
Modulates glutamate homeostasis in the central nervous system[4]

Neuroprotective Effects:

Inhibits microglial activation in neuropathic pain models[6]
Reduces spinal cord neuroinflammation[6][28]
– Protects against oxidative damage to neural tissues[26]

—

5. NAC’S IMPACT ON PAIN PROCESSING

Pain processing refers to how pain signals are processed from the initial damaged tissue source of pain through the nerves and spinal cord to the brain and then down the spinal cord again. Nutraceuticals offer potential benefit for reducing the severity of the pain experience by acting at various levels of pain processing. These benefits are independent of the benefits the nutraceutical offers at the source of pain.

Level 1: Peripheral Pain Receptor (Nociception Transduction)

NAC modulates peripheral nociception through:

Reduction of oxidative stress at tissue level[26]
Antagonism of NGF-TrkA signaling that sensitizes nociceptors[9]
Reduction of local inflammatory mediators[14]

Level 2: Primary Afferent Transmission to Spinal Cord

NAC supports healthy nerve signal transmission:
Protects peripheral nerves from oxidative damage[26]
Reduces nitric oxide metabolites in spinal cord[28]
Modulates MMP activity affecting nerve function[6]

Level 3: Spinal Cord Dorsal Horn Processing (First Synapse)

NAC significantly affects spinal cord processing through:

Inhibition of spinal microglial activation[6]
Suppression of MMP-9/2 activity in spinal cord[6]
Blocking IL-1β maturation at spinal level[6]
Inhibition of PKCγ, NMDAR1, and MAPK phosphorylation[6]
Modulation of glutathione system and reduction of nitric oxide metabolites[28]

Level 4: Ascending Spinal Pathways and Supraspinal Processing

NAC affects higher pain processing centers:

Activates mGlu2 receptors that modulate ascending pain transmission[7][8]
Reduces neuroinflammation in supraspinal structures[29]
Modulates glutamate homeostasis[4]

Level 5: Brain Cortical Processing and Pain Perception

NAC modulates the conscious experience of pain through:

Neuroprotective effects in cortical regions[29]
Reduction of neuroinflammatory cytokines in brain tissue[29]
Modulation of glutamatergic transmission affecting pain perception[7]
Potential effects on mood and anxiety associated with chronic pain[30]

Level 6: Descending Pain Modulation

NAC may support descending inhibitory pathways through:

Enhancement of mGlu2 receptor-mediated analgesia[7][8]
Reduction of central neuroinflammation[29]
Restoration of glutamate homeostasis[4]

Clinical Evidence for Effects on Pain Processing:

NAC (1.2 g oral) significantly reduced pain ratings to laser stimuli and amplitudes of laser-evoked potentials in healthy human volunteers, demonstrating direct effects on nociceptive transmission. This effect was replicated in mice and abolished by mGlu2/3 receptor antagonists.[7]

—

6. BENEFITS FOR PAIN SENSITIZATION

Peripheral Sensitization: LOW-MODERATE Quality Evidence

NAC reduces peripheral sensitization through:

Antagonism of NGF-TrkA signaling that sensitizes peripheral nociceptors[9]
Reduction of peripheral oxidative stress and inflammatory mediators[14]
Inhibition of MMP activity that facilitates inflammatory cytokine maturation[6]
Reduction of lipid hydroperoxides at tissue level[26]

Central Sensitization: MODERATE Quality Evidence

NAC addresses central sensitization through:

Inhibition of spinal microglial activation[6]
Suppression of spinal MMP-9/2 activity[6]
Blocking phosphorylation of PKCγ, NMDAR1, and MAPKs in spinal cord[6]
Activation of mGlu2 receptors via cystine/glutamate antiporter[7][8]
Modulation of glutamate homeostasis in CNS[4]
Reduction of spinal nitric oxide metabolites[28]
Potential role as TrkA antagonist affecting spinal cord sensitization[9]

—

7. NAC’S IMPACT ON THE 4 DRIVING FORCES OF CHRONIC PAIN

1. Systemic Inflammation: MODERATE EFFECT

NAC reduces systemic inflammation through:

Suppression of NF-κB activity[1]
Reduction of TNF-α, IL-6, and IL-1β levels[1]
Meta-analysis: NAC supplementation significantly diminishes IL-6 (p=0.03) and TBARS (p=0.02) concentrations[27]
Clinical study: NAC significantly reduced IL-6, TNF-α, and IL-1β in patients at risk forRPS[14]

2. Neuroinflammation: MODERATE-STRONG EFFECT

NAC potently reduces neuroinflammation through:

Inhibition of microglial activation in spinal cord[6][10]
Suppression of MMP-9/2 that facilitate inflammatory cytokine maturation[6]
Blocking IL-1β maturation in neural tissues[6]
Reduction of TNF-α and IL-1β production from activated microglia[10]
Promotion of neuronal survival by inhibiting microglial phagocytosis[10]
Modulation of glutamate homeostasis affecting neuroinflammation[4][29]

3. Oxidative Stress: STRONG EFFECT (Primary Mechanism)

This is NAC’s primary mechanism of action:

Serves as precursor for glutathione synthesis[1][2][5]
Meta-analysis: NAC significantly increases GSH levels and reduces TBARS after exercise[27]
Increases total antioxidant capacity (TAC) and superoxide dismutase (SOD) activity[14]
Reduces total oxidant status (TOS) and oxidative stress index[14]
Clinical study: NAC reduced phosphatidylserine exposure (marker of cellular oxidative damage) and advanced glycation end-products in sickle cell patients[31]
Reduces lipid hydroperoxides in spinal cord[26]

4. Mitochondrial Dysfunction: MODERATE EFFECT

NAC supports mitochondrial function:

Protects mitochondria from oxidative damage[29]
Maintains mitochondrial homeostasis in oxidative stress conditions[23]
Reduces mitochondrial dysfunction associated with neuroinflammation[29]
NAC-derived carbon dots maintain mitochondrial function in disc degeneration models[23]

—

8. DOSING, TIMING, DURATION AND ADMINISTRATION

Recommended Dosing:

CRPS prevention

Dose: 600 mg
Frequency: Once daily
Duration: 3 months

CRPS treatment

Dose: 600 mg
Frequency: Three times daily
Duration: 17 weeks minimum

Endometriosis pain

Dose: 600 mg x 3 tablets
Frequency: 3 consecutive days/week
Duration: 3 months

General chronic pain

Dose: 600-1200 mg
Frequency: 1-2 times daily
Duration: 4-12 weeks

Psychiatric/neurological

Dose: 000-2400 mg
Frequency: Divided doses
Duration: Ongoing

Key Dosing Points:

Most clinical trials for chronic pain used doses of 600-2400 mg/day[13][14][19]
For psychiatric and neurological conditions, recommended dosage is 2000-2400 mg/day[32]
Higher doses (up to 3000 mg/day) have been studied safely in chronic respiratory diseases[11]
Oral bioavailability is approximately 6-10%[18]
Peak plasma concentration achieved within 1-2 hours[18]

Timing:

Can be taken with or without food
Divide total daily dose into 2-3 doses for higher dosing regimens
Effervescent tablets may be better tolerated than capsules

Duration of Onset:

Antioxidant effects: May begin within days to weeks
Pain reduction: Typically 4-12 weeks for meaningful improvement[14][19]
CRPS prevention: 3 months of treatment studied[14]
Long-term use appears safe based on respiratory disease studies[11]

—

9. FORMULATION CONSIDERATIONS

Available Formulations:

Oral capsules/tablets: 500-600 mg most common
Effervescent tablets: 600 mg (may improve tolerability)
Powder: Can be mixed with beverages
Intravenous: Used for acetaminophen overdose (not for routine supplementation)

Bioavailability Considerations:

Oral bioavailability is low (6-10%)[18]
Activated charcoal may interfere with absorption (up to 96% adsorbed)[18]
Terminal half-life approximately 6.25 hours[18]
Protein binding reaches approximately 50% at 4 hours[18]

Quality Considerations:

Choose products from reputable manufacturers with third-party testing
Look for USP or NSF certification
Effervescent formulations may be better tolerated for GI-sensitive patients
Store in cool, dry place; color change to light purple does not affect efficacy[33]

Important Note: NAC should not be considered a powerful antioxidant in its own right—its strength is the targeted replenishment of glutathione in GSH-deficient cells. It is likely to be less effective in cells replete with GSH.[5]

—

10. SYNERGIES WITH OTHER PAIN MEDICATIONS AND NUTRACEUTICALS

Nutraceuticals:

Alpha-Lipoic Acid: Complementary antioxidant mechanisms; combination studied in endometriosis pain[21]
Bromelain: Anti-inflammatory enzyme; combination with NAC and alpha-lipoic acid showed benefit in endometriosis[21]
Curcumin: Both target oxidative stress and inflammation through different pathways; curcumin inhibits NF-κB while NAC replenishes glutathione[34]
Omega-3 Fatty Acids: Complementary anti-inflammatory mechanisms
Vitamin C and E: Complementary antioxidants; NAC suppressed nociception induced by oxidatively modified lipoproteins similar to vitamin E[22]
Coenzyme Q10: Complementary mitochondrial support

Conventional Medications:

Acetaminophen: NAC is the antidote for acetaminophen overdose by restoring hepatic glutathione; safe to use together at therapeutic doses[33]
NSAIDs: NAC may complement NSAIDs by addressing oxidative stress component of pain; indomethacin and NAC both suppressed oxidation-sensitive nociception[22]
Gabapentinoids: May have complementary mechanisms; NAC modulates glutamate while gabapentinoids affect calcium channels
Antidepressants: NAC has been studied as adjunctive therapy in depression and may complement antidepressant effects[30][32]

—

11. DRUG INTERACTIONS

Potential Interactions to Monitor:

Activated Charcoal:

Up to 96% of NAC may be adsorbed onto charcoal[18]
Avoid concurrent administration if using NAC therapeutically

Nitroglycerin:

NAC may potentiate the vasodilatory effects of nitroglycerin
Monitor for hypotension if used concurrently

Antibiotics (Nebulized NAC):

NAC solution should not be mixed with tetracycline, oxytetracycline, or erythromycin lactobionate in nebulizer[33]
Oral NAC does not have this interaction

Chemotherapy Agents:

Theoretical concern that antioxidants may interfere with oxidative mechanisms of some chemotherapy drugs
Consult oncologist before use

Anticoagulants:

No significant interactions reported, but monitor as with any supplement

Safe Combinations:

Generally safe with most pain medications at recommended doses
No significant interactions reported with acetaminophen at therapeutic doses
Can be combined with other antioxidant supplements
Safe as adjunctive therapy with psychiatric medications[32]

Important Clinical Context:

Drug interactions of clinical significance have been observed with acetaminophen (beneficial—NAC is the antidote), glutathione, and anticancer agents[18]
NAC has an excellent profile of safety and tolerability when used clinically[8]

—

12. SAFETY AND CONTRAINDICATIONS

Excellent Safety Profile:
NAC has a well-established safety profile with decades of clinical use:[1][11]
Included on WHO Model List of Essential Medicines[4]
Safe at doses up to 3000 mg/day in chronic respiratory disease studies[11]
Toxicity is uncommon and dependent on route of administration and high dosages[1]
No significant differences in adverse events between NAC and placebo in most studies[11]
Non-mutagenic and non-carcinogenic in animal studies[33]

Possible Side Effects (generally mild):

Gastrointestinal symptoms: nausea, vomiting, diarrhea (most common)[33][35]
Unpleasant sulfurous odor/taste
Headache (rare)
Skin rash (rare)[33]
Pruritus (rare)[24]

Contraindications:

Known allergy to NAC or acetylcysteine
Active peptic ulcer disease or esophageal varices (oral high-dose use)[33]
Severe asthma (inhaled formulation may cause bronchospasm)

Who Should Use Caution:

Patients with asthma (inhaled NAC may trigger bronchospasm)
Patients on nitroglycerin (may potentiate hypotensive effects)
Patients receiving chemotherapy (consult oncologist)
Pregnancy and breastfeeding (insufficient safety data for high-dose supplementation)

Important Safety Notes:

Oral NAC is safe and well tolerated without considerable adverse effects[32]
Side effects may increase at very high doses (>6 g/day)[35]
Gastrointestinal symptoms are no more common than in control groups in most studies[11]

—

13. SPECIAL CONSIDERATIONS / TIPS

Understand the mechanism: NAC works primarily by replenishing glutathione in depleted cells; it may be less effective if glutathione levels are already normal[5]
Be patient: Allow 4-12 weeks for meaningful improvement in chronic pain conditions[14][19]
Consider the pain type: NAC may be more effective for inflammatory pain than neuropathic pain; tolerance may develop with repeated use in neuropathic pain[8]
CRPS subtype matters: NAC appears more effective for “cold” CRPS-I, while DMSO may be better for “warm” CRPS-I[19]
Sulfurous odor: NAC has a characteristic sulfur smell; effervescent tablets may be more palatable
Timing for CRPS prevention: Start NAC early after injury (e.g., distal radius fracture) for prevention[14]
Combination approach: NAC may work best in combination with other antioxidants (alpha-lipoic acid, bromelain) for endometriosis[21]
No tolerance for inflammatory pain: Unlike neuropathic pain, NAC retained analgesic activity with repeated dosing in inflammatory pain models[8]
Complementary approach: NAC works best as part of a comprehensive pain management plan
Monitor if on chemotherapy: Inform your oncologist about NAC use

—

14. COSTS

Standard NAC capsules (600 mg): $10-20 per month
Effervescent tablets (600 mg): $15-25 per month
Sustained-release formulations: $20-35 per month
Combination products (NAC + alpha-lipoic acid): $25-40 per month

NAC is available as a dietary supplement without prescription in most countries. It is inexpensive and commercially available.[12] Compared to prescription pain medications and their associated monitoring costs, NAC may be cost-effective for appropriate patients, particularly those with conditions characterized by oxidative stress.

—

Remember: NAC works best as part of a comprehensive pain management plan that includes proper medical care, physical activity, stress management, and healthy nutrition. NAC is particularly valuable for pain conditions characterized by oxidative stress and inflammation, such as CRPS, endometriosis-related pain, and inflammatory pain conditions. Its excellent safety profile makes it suitable for long-term use. The evidence base for NAC in chronic pain is still developing, and larger clinical trials are needed to establish definitive recommendations. Always discuss any new supplement with your healthcare provider before starting.

The evidence for NAC in chronic pain is more limited than for curcumin, with most high-quality evidence coming from preclinical studies and smaller clinical trials. The strongest clinical evidence exists for CRPS prevention/treatment and endometriosis-related pelvic pain, while evidence for other chronic pain conditions remains preliminary.

References

-Acetylcysteine (NAC): Impacts on Human Health. Tenório MCDS, Graciliano NG, Moura FA, Oliveira ACM, Goulart MOF. Antioxidants (Basel, Switzerland). 2021;10(6):967. doi:10.3390/antiox10060967.
N-Acetylcysteine as an Antioxidant and Disulphide Breaking Agent: The Reasons Why. Aldini G, Altomare A, Baron G, et al. Free Radical Research. 2018;52(7):751-762. doi:10.1080/10715762.2018.1468564.
The Mechanism of Action of N-Acetylcysteine (NAC): The Emerging Role of HS and Sulfane Sulfur Species. Pedre B, Barayeu U, Ezeriņa D, Dick TP. Pharmacology & Therapeutics. 2021;228:107916. doi:10.1016/j.pharmthera.2021.107916.
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Raghu G, Berk M, Campochiaro PA, et al. Current Neuropharmacology. 2021;19(8):1202-1224. doi:10.2174/1570159X19666201230144109.
Existing and Potential Therapeutic Uses for N-Acetylcysteine: The Need for Conversion to Intracellular Glutathione for Antioxidant Benefits. Rushworth GF, Megson IL. Pharmacology & Therapeutics. 2014;141(2):150-9. doi:10.1016/j.pharmthera.2013.09.006.
N-Acetyl-Cysteine Attenuates Neuropathic Pain by Suppressing Matrix Metalloproteinases. Li J, Xu L, Deng X, et al. Pain. 2016;157(8):1711-1723. doi:10.1097/j.pain.0000000000000575.
N-Acetyl-Cysteine, a Drug That Enhances the Endogenous Activation of Group-Ii Metabotropic Glutamate Receptors, Inhibits Nociceptive Transmission in Humans. Truini A, Piroso S, Pasquale E, et al. Molecular Pain. 2015;11:14. doi:10.1186/s12990-015-0009-2.
N-Acetyl-Cysteine Causes Analgesia by Reinforcing the Endogenous Activation of Type-2 Metabotropic Glutamate Receptors. Bernabucci M, Notartomaso S, Zappulla C, et al. Molecular Pain. 2012;8:77. doi:10.1186/1744-8069-8-77.
N-Acetylcysteine Antagonizes NGF Activation of TrkA Through Disulfide Bridge Interaction, an Effect Which May Contribute to Its Analgesic Activity. Govoni S, Fantucci P, Marchesi N, et al. International Journal of Molecular Sciences. 2023;25(1):206. doi:10.3390/ijms25010206.
Redox Potential-Sensitive N-Acetyl Cysteine-Prodrug Nanoparticles Inhibit the Activation of Microglia and Improve Neuronal Survival. Markoutsa E, Xu P. Molecular Pharmaceutics. 2017;14(5):1591-1600. doi:10.1021/acs.molpharmaceut.6b01028.
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review. Calverley P, Rogliani P, Papi A. Drug Safety. 2021;44(3):273-290. doi:10.1007/s40264-020-01026-y.
Potential of N-Acetylcysteine in the Management of Low Back Pain: A Scoping Review of Studies in Humans and Animal Models. Sinigaglia G, Fortunato LM, Grillo ML, Partata WA. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 2025;58:e14382. doi:10.1590/1414-431X2025e14382.
Efficacy and Safety of N-Acetylcysteine for the Management of Chronic Pain in Adults: A Systematic Review and Meta-Analysis. Mohiuddin M, Pivetta B, Gilron I, Khan JS. Pain Medicine (Malden, Mass.). 2021;22(12):2896-2907. doi:10.1093/pm/pnab042.
Efficacy of N-Acetylcysteine in Reducing Inflammation and Oxidative Stress to Prevent Complex Regional Pain Syndrome Type 1. Dinç M, Soydemir ÖC. Medicine. 2024;103(38):e39742. doi:10.1097/MD.0000000000039742.
Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes. Anastasi E, Scaramuzzino S, Viscardi MF, et al. International Journal of Environmental Research and Public Health. 2023;20(6):4686. doi:10.3390/ijerph20064686.
Medical and Dietary Uses of N-Acetylcysteine. Šalamon Š, Kramar B, Marolt TP, Poljšak B, Milisav I. Antioxidants (Basel, Switzerland). 2019;8(5):E111. doi:10.3390/antiox8050111.
Clinical and Nutritional Benefits of Cysteine-Enriched Protein Supplements. McPherson RA, Hardy G. Current Opinion in Clinical Nutrition and Metabolic Care. 2011;14(6):562-8. doi:10.1097/MCO.0b013e32834c1780.
Clinical Pharmacokinetics of N-Acetylcysteine. Holdiness MR. Clinical Pharmacokinetics. 1991;20(2):123-34. doi:10.2165/00003088-199120020-00004.
The Treatment of Complex Regional Pain Syndrome Type I With Free Radical Scavengers: A Randomized Controlled Study. Perez MRSG, Zuurmond AWW, Bezemer DP, et al. Pain. 2003;102(3):297-307. doi:10.1016/S0304-3959(02)00414-1.
Interventions for Treating Pain and Disability in Adults With Complex Regional Pain Syndrome- An Overview of Systematic Reviews. Ferraro MC, Cashin AG, Wand BM, et al. The Cochrane Database of Systematic Reviews. 2023;6:CD009416. doi:10.1002/14651858.CD009416.pub3.
Effectiveness of an Antioxidant Preparation With N-Acetyl Cysteine, Alpha Lipoic Acid and Bromelain in the Treatment of Endometriosis-Associated Pelvic Pain: LEAP Study. Lete I, Mendoza N, de la Viuda E, Carmona F. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2018;228:221-224. doi:10.1016/j.ejogrb.2018.07.002.
Oxidation-Sensitive Nociception Involved in Endometriosis-Associated Pain. Ray K, Fahrmann J, Mitchell B, et al. Pain. 2015;156(3):528-539. doi:10.1097/01.j.pain.0000460321.72396.88.
N-Acetylcysteine-Derived Carbon Dots for Free Radical Scavenging in Intervertebral Disc Degeneration. Wu S, Shi Y, Jiang L, et al. Advanced Healthcare Materials. 2023;12(24):e2300533. doi:10.1002/adhm.202300533.
Antioxidant Supplementation for Sickle Cell Disease. Bolarinwa AB, Oduwole O, Okebe J, et al. The Cochrane Database of Systematic Reviews. 2024;5:CD013590. doi:10.1002/14651858.CD013590.pub2.
Effects of N-Acetylcysteine on Dense Cell Formation in Sickle Cell Disease. Pace BS, Shartava A, Pack-Mabien A, et al. American Journal of Hematology. 2003;73(1):26-32. doi:10.1002/ajh.10321.
Effects of N-Acetylcysteine on Spinal Cord Oxidative Stress Biomarkers in Rats With Neuropathic Pain. Horst A, de Souza JA, Santos MCQ, et al. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas. 2017;50(12):e6533. doi:10.1590/1414-431X20176533.
The Impact of N-Acetylcysteine on Lactate, Biomarkers of Oxidative Stress, Immune Response, and Muscle Damage: A Systematic Review and Meta-Analysis. Sadowski M, Zawieja E, Chmurzynska A. Journal of Cellular and Molecular Medicine. 2024;28(23):e70198. doi:10.1111/jcmm.70198.
Effect of N-Acetylcysteine on the Spinal-Cord Glutathione System and Nitric-Oxide Metabolites in Rats With Neuropathic Pain. Horst A, Kolberg C, Moraes MS, et al. Neuroscience Letters. 2014;569:163-8. doi:10.1016/j.neulet.2014.03.063.
The Neuroprotective Effects of N-Acetylcysteine in Psychiatric and Neurodegenerative Disorders: From Modulation of Glutamatergic Transmission to Restoration of Synaptic Plasticity. Chakraborty S, Shankaranarayana Rao BS, Tripathi SJ. Neuropharmacology. 2025;278:110527. doi:10.1016/j.neuropharm.2025.110527.
Clinical Trials of N-Acetylcysteine in Psychiatry and Neurology: A Systematic Review. Deepmala, Slattery J, Kumar N, et al. Neuroscience and Biobehavioral Reviews. 2015;55:294-321. doi:10.1016/j.neubiorev.2015.04.015.
N-Acetylcysteine Reduces Oxidative Stress in Sickle Cell Patients. Nur E, Brandjes DP, Teerlink T, et al. Annals of Hematology. 2012;91(7):1097-105. doi:10.1007/s00277-011-1404-z.
N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence. Ooi SL, Green R, Pak SC. BioMed Research International. 2018;2018:2469486. doi:10.1155/2018/2469486.
Acetylcysteine. Food and Drug Administration. Updated date: 2025-05-29.
Targeting Oxidative Stress Involved in Endometriosis and Its Pain. Clower L, Fleshman T, Geldenhuys WJ, Santanam N. Biomolecules. 2022;12(8):1055. doi:10.3390/biom12081055.
Performance and Side Effects of Supplementation With N-Acetylcysteine: A Systematic Review and Meta-Analysis. Rhodes K, Braakhuis A. Sports Medicine (Auckland, N.Z.). 2017;47(8):1619-1636. doi:10.1007/s40279-017-0677-3.

Emphasis on Education

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

Should you wish more information regarding any of the subjects listed – or not listed – here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

For more information, please contact Accurate Clinic.

Supplements recommended by Dr. Ehlenberger may be purchased commercially online

Please read about our statement regarding the sale of products recommended by Dr. Ehlenberger.